rs1555612294
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The ENST00000358273.9(NF1):c.1527+1_1527+4delGTAA variant causes a splice donor, splice region, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,460,490 control chromosomes in the GnomAD database, with no homozygous occurrence. 1/1 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
ENST00000358273.9 splice_donor, splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NF1 | NM_001042492.3 | c.1527+4_1527+7delAGTA | splice_region_variant, intron_variant | Intron 13 of 57 | ENST00000358273.9 | NP_001035957.1 | ||
NF1 | NM_000267.3 | c.1527+4_1527+7delAGTA | splice_region_variant, intron_variant | Intron 13 of 56 | NP_000258.1 | |||
NF1 | NM_001128147.3 | c.1527+4_1527+7delAGTA | splice_region_variant, intron_variant | Intron 13 of 14 | NP_001121619.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1460490Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 726606
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neurofibromatosis, type 1 Pathogenic:3
This sequence change falls in intron 13 of the NF1 gene. It does not directly change the encoded amino acid sequence of the NF1 protein. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individual(s) with neurofibromatosis type 1 (PMID: 11258625, 12807981; internal data). This variant is also known as IVS10b+4delAGTA or IVS10b+2delTAAG. ClinVar contains an entry for this variant (Variation ID: 457536). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 13, but is expected to preserve the integrity of the reading-frame (PMID: 11258625). For these reasons, this variant has been classified as Pathogenic. -
- -
- -
not provided Pathogenic:2
The NF1 c.1527+4_1527+7del variant has been reported in the published literature in individuals with neurofibromatosis 1, including one individual where the variant was reported to occur de novo (PMID: 38405018 (2024), 27322474 (2016), 18546366 (2008), 12807981 (2003)). Functional studies demonstrated that this variant disrupted mRNA splicing, however exon skipping was in-frame (PMID: 27322474 (2016), 12807981 (2003)). This variant has not been reported in large, multi-ethnic general populations (Genome Aggregation Database, http://gnomad.broadinstitute.org). Analysis of this variant using software algorithms for the prediction of the effect of nucleotide changes on splicing yielded predictions that this variant may affect proper NF1 mRNA splicing. Based on the available information, this variant is classified as likely pathogenic. -
Non-canonical splice site variant demonstrated to result in aberrant splicing leading to loss of the adjacent exon (Messiaen et al., 1999; Pros et al., 2008; Evans et al., 2016); Deletions involving coding exons of this gene are a known mechanism of disease (HGMD); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on splicing; Also known as IVS10b+2delTAAG; This variant is associated with the following publications: (PMID: 11258625, 18546366, 27322474, 17576681, 9536098, 12807981, Bakir2023) -
Hereditary cancer-predisposing syndrome;CN230736:Cardiovascular phenotype Pathogenic:1
The c.1527+4_1527+7delAGTA intronic variant is located 4 nucleotides after coding exon 13 of the NF1 gene. This variant results from a deletion of 4 nucleotides at positions c.1527+4 to c.1527+7. This alteration has been detected in multiple individuals meeting diagnostic criteria or suspicious for neurofibromatosis type 1 (NF1) (Messiaen LM et al. Genet Med. 1999 Sep-Oct;1(6):248-53; Ars E et al. J Med Genet. 2003 Jun;40(6):e82; Evans DG et al. EBioMedicine. 2016 May;7:212-20). RNA analysis demonstrated that this alteration causes in-frame skipping of coding exon 13 (Messiaen LM et al. Genet Med. 1999 Sep-Oct;1(6):248-53; Ars E et al. J Med Genet. 2003 Jun;40(6):e82). In silico splice site analysis predicts that this alteration will weaken the native splice donor site. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as likely pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at